Biogen Says Growth Products Lifts Revenue, Sees No Impact From Macro Uncertainty

Date:




Biogen first-quarter profit and revenue rose, buoyed by rising sales from its growth products, led by its drug to treat early Alzheimer’s.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Human remains found between two walls in Ruidoso Downs identified

RUIDOSO DOWNS, N.M. (KRQE) – Mummified human remains that were...

‘Ransom Canyon’ Reveals Season 2 Premiere Date

Ransom Canyon Season 2 is coming to Netflix sooner...

KPMG to Lay Off 4% of U.S. Advisory Workforce

The Big Four accounting firm has been grappling with...

Sources: Warriors’ brass meet with Kerr; will reconvene next week

, Ramona ShelburneCloseRamona ShelburneESPN Senior WriterSenior writer for ESPN.comSpent seven...